Michael Zinda - 23 Nov 2021 Form 4 Insider Report for Repare Therapeutics Inc. (RPTX)

Role
EVP, Chief Science Officer
Signature
/s/ Steve Forte, Attorney-in-Fact
Issuer symbol
RPTX
Transactions as of
23 Nov 2021
Net transactions value
+$91,948
Form type
4
Filing time
06 Dec 2021, 15:47:14 UTC
Previous filing
17 Nov 2021
Next filing
20 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPTX Common Shares Options Exercise $6,748 +4,122 +773% $1.64* 4,655 23 Nov 2021 Direct
transaction RPTX Common Shares Options Exercise $19,408 +11,856 +255% $1.64* 16,511 23 Nov 2021 Direct
transaction RPTX Common Shares Options Exercise $40,395 +19,590 +119% $2.06* 36,101 23 Nov 2021 Direct
transaction RPTX Common Shares Options Exercise $25,397 +10,473 +29% $2.42* 46,574 23 Nov 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RPTX Employee Stock Option (right to buy) Options Exercise $0 -4,122 -100% $0.000000* 0 23 Nov 2021 Common Shares 4,122 $1.64 Direct F1
transaction RPTX Employee Stock Option (right to buy) Options Exercise $0 -11,856 -100% $0.000000* 0 23 Nov 2021 Common Shares 11,856 $1.64 Direct F1
transaction RPTX Employee Stock Option (right to buy) Options Exercise $0 -19,590 -36% $0.000000 35,260 23 Nov 2021 Common Shares 19,590 $2.06 Direct F2
transaction RPTX Employee Stock Option (right to buy) Options Exercise $0 -10,473 -7.1% $0.000000 137,993 23 Nov 2021 Common Shares 10,473 $2.42 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested and exercisable.
F2 Twenty-five percent (25%) of the shares subject to the option vested on March 29, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.
F3 Twenty-five percent (25%) of the shares subject to the option vested on December 16, 2020, and one thirty-ninth (1/39th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.